# A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty

> **NCT05034952** · PHASE2 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 303 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** VX-548
- **DRUG:** HB/APAP
- **DRUG:** Placebo (matched to VX-548)
- **DRUG:** Placebo (matched to HB/APAP)

## Key facts

- **NCT ID:** NCT05034952
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-30
- **Primary completion:** 2021-12-05
- **Final completion:** 2021-12-21
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05034952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05034952, "A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05034952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*